Free tool
FAERS Monitor: Praluent
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 125559 or its brand name (Praluent, Alirocumab). Reports on generic versions are filed under their own applications.
Reports
25,752
Serious
6,952
27% of reports
Hospitalization
2,674
Death reported
511
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- myalgia1,710
- injection site pain1,406
- product dose omission1,363
- muscle spasms1,209
- arthralgia1,088
- fatigue1,054
- pain979
- pain in extremity959
- product dose omission issue926
- injection site bruising905
- diarrhoea833
- headache823
- influenza like illness811
- device issue791
- injection site haemorrhage752
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2008 | 1 |
| 2015 | 297 |
| 2016 | 2,738 |
| 2017 | 3,158 |
| 2018 | 4,179 |
| 2019 | 4,511 |
| 2020 | 2,093 |
| 2021 | 1,741 |
| 2022 | 1,662 |
| 2023 | 1,583 |
| 2024 | 1,364 |
| 2025 | 1,110 |
| 2026 | 1,315 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,028,407 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| product dose omissionSignal | 1,363 | 17.4 | 16.5 | 20,671 |
| injection site bruisingSignal | 905 | 9.4 | 8.8 | 6,698 |
| myalgiaSignal | 1,710 | 8.3 | 7.9 | 10,930 |
| influenza like illnessSignal | 811 | 8.1 | 7.6 | 5,025 |
| injection site haemorrhageSignal | 752 | 7.8 | 7.2 | 4,392 |
| device issueSignal | 791 | 7.3 | 6.8 | 4,243 |
| muscle spasmsSignal | 1,209 | 5.4 | 5.1 | 4,351 |
| injection site painSignal | 1,406 | 3.8 | 3.6 | 2,870 |
| pain in extremitySignal | 959 | 2.7 | 2.5 | 1,006 |
| product dose omission issueSignal | 926 | 2.6 | 2.4 | 902 |
| arthralgiaSignal | 1,088 | 2.1 | 2.0 | 671 |
| pain | 979 | 1.3 | 1.2 | 70 |
| fatigue | 1,054 | 1.1 | 1.0 | 11 |
| headache | 823 | 1.1 | 1.0 | 4 |
| diarrhoea | 833 | 1.1 | 1.0 | 2 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.